Collegium Pharmaceutical Inc (COLL)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The data provided for Collegium Pharmaceutical Inc shows that the days of sales outstanding (DSO) figures are not available for any of the periods mentioned, spanning from March 31, 2020, to December 31, 2024. This indicates that specific information regarding the DSO metric for Collegium Pharmaceutical Inc during these time frames is not disclosed or provided in the dataset.
In general, the DSO ratio is a measure of how long it takes a company to collect payments from its customers after a sale has been made. A lower DSO typically indicates that the company is efficient in collecting payments and managing its accounts receivable, while a higher DSO may suggest potential issues with collections efficiency or credit policies.
Since the DSO data is not available in the provided dataset, it is not possible to analyze Collegium Pharmaceutical Inc's efficiency in collecting payments from customers over time based on this specific metric. Additional information or data points would be needed to conduct a more thorough analysis of the company's accounts receivable management and overall financial performance in relation to its sales.
Peer comparison
Dec 31, 2024